Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSEARCA:COMCNSX:PREVOTCMKTS:TNGN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOMDirexion Auspice Broad Commodity Strategy ETF$29.24+0.2%$28.50$27.56▼$31.62$260.24M0.1946,944 shs33,009 shsPREVPreveCeutical Medical$0.00$0.00▼$0.00N/AN/AN/A694,224 shsTNGNTengion$0.00$0.00▼$0.00N/AN/A6,051 shs10,000 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOMDirexion Auspice Broad Commodity Strategy ETF+0.17%-0.31%+3.87%+5.29%-6.64%PREVPreveCeutical Medical0.00%0.00%0.00%0.00%0.00%Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCOMDirexion Auspice Broad Commodity Strategy ETFN/AN/AN/AN/AN/AN/AN/AN/APREVPreveCeutical MedicalN/AN/AN/AN/AN/AN/AN/AN/ATNGNTengionN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOMDirexion Auspice Broad Commodity Strategy ETF0.00N/AN/AN/APREVPreveCeutical MedicalN/AN/AN/AN/ATNGNTengionN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOMDirexion Auspice Broad Commodity Strategy ETFN/AN/AN/AN/AN/AN/APREVPreveCeutical MedicalN/AN/AN/AN/AN/AN/ATNGNTengionN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOMDirexion Auspice Broad Commodity Strategy ETFN/AN/A0.00∞N/AN/AN/AN/AN/APREVPreveCeutical MedicalN/AN/A0.00N/AN/AN/AN/AN/AN/ATNGNTengionN/AN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOMDirexion Auspice Broad Commodity Strategy ETF$2.538.65%N/AN/AN/APREVPreveCeutical MedicalN/AN/AN/AN/AN/ATNGNTengionN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOMDirexion Auspice Broad Commodity Strategy ETFN/APREVPreveCeutical MedicalN/ATNGNTengionN/AInsider OwnershipCompanyInsider OwnershipCOMDirexion Auspice Broad Commodity Strategy ETFN/APREVPreveCeutical MedicalN/ATNGNTengionN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCOMDirexion Auspice Broad Commodity Strategy ETFN/A8.90 millionN/ANot OptionablePREVPreveCeutical MedicalN/AN/AN/ANot OptionableTNGNTengion147,000N/AN/ANot OptionableANR, PREV, TNGN, and COM HeadlinesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioPalantir Technologies: Bearish Sentiment, Bullish Chart SignalsMarch 27, 2024 7:30 AMView Palantir Technologies: Bearish Sentiment, Bullish Chart SignalsGreen Gold Rush: Here's What's Driving Cannabis Stocks HigherApril 2, 2024 7:17 AMView Green Gold Rush: Here's What's Driving Cannabis Stocks HigherBargain Hunting: 3 Stocks With RSIs That Scream OversoldApril 19, 2024 8:59 AMView Bargain Hunting: 3 Stocks With RSIs That Scream OversoldWhat is the Nasdaq? Complete Overview with HistoryApril 16, 2024 8:00 AMView What is the Nasdaq? Complete Overview with HistoryAll Headlines Company DescriptionsDirexion Auspice Broad Commodity Strategy ETFNYSEARCA:COMThe Direxion Auspice Broad Commodity Strategy ETF (COM) is an exchange-traded fund that is based on the Auspice Broad Commodity index. The fund tracks a broad-market index consisting of 12 commodity futures contracts, weighted by historical volatility, which can toggle to cash based on momentum. The fund will also hold short-term fixed income securities as collateral. COM was launched on Mar 30, 2017 and is managed by Direxion.PreveCeutical MedicalCNSX:PREVPreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.TengionOTCMKTS:TNGNTengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
